IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Hepatobiliary and Pancreatic Diseases International

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

1.89

h-Index

2022-2023

 53

Rank

2022-2023

 7217

SJR

2022-2023

 0.691

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Hepatobiliary and Pancreatic Diseases International
Abbreviation Hepatobiliary Pancreat. Dis. Int.
Publication Type Journal
Subject Area, Categories, Scope Gastroenterology (Q2); Hepatology (Q2)
h-index 53
Overall Rank/Ranking 7217
SCImago Journal Rank (SJR) 0.691
Impact Score 1.89
Publisher Elsevier (Singapore) Pte Ltd
Country Singapore
ISSN 14993872
Best Quartile Q2
Coverage History 2002-2022




Aim and Scope


Hepatobiliary & Pancreatic Diseases International (HBPD INT) publishes peer-reviewed original papers, reviews and editorials concerned with clinical practice and research in the fields of hepatobiliary and pancreatic diseases. Papers cover the medical, surgical, radiological, pathological, biochemical, physiological and historical aspects of the subject areas under the headings Liver, Biliary, Pancreas, Transplantation, Research, Special Reports, Editorials, Review Articles, Brief Communications, Clinical Summary, Clinical Images and Case Reports. The journal also deals with the basic sciences and experimental work.


About Hepatobiliary and Pancreatic Diseases International


Hepatobiliary and Pancreatic Diseases International is a journal covering the technologies/fields/categories related to Gastroenterology (Q2); Hepatology (Q2). It is published by Elsevier (Singapore) Pte Ltd. The overall rank of Hepatobiliary and Pancreatic Diseases International is 7217. According to SCImago Journal Rank (SJR), this journal is ranked 0.691. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 53. The best quartile for this journal is Q2.

The ISSN of Hepatobiliary and Pancreatic Diseases International journal is 14993872. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Hepatobiliary and Pancreatic Diseases International is cited by a total of 682 articles during the last 3 years (Preceding 2022).


Hepatobiliary and Pancreatic Diseases International Impact IF 2022-2023


The Impact IF 2022 of Hepatobiliary and Pancreatic Diseases International is 1.89, which is computed in 2023 as per its definition. Hepatobiliary and Pancreatic Diseases International IF is decreased by a factor of 0.1 and approximate percentage change is -5.03% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Hepatobiliary and Pancreatic Diseases International Impact IF 2023 Prediction


Impact IF 2022 of Hepatobiliary and Pancreatic Diseases International is 1.89. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Hepatobiliary and Pancreatic Diseases International. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 1.89
2021 1.99
2020 2.22
2019 1.86
2018 1.34
2017 1.51
2016 1.67
2015 1.87
2014 1.88

Hepatobiliary and Pancreatic Diseases International h-index


  Table Setting

Hepatobiliary and Pancreatic Diseases International has an h-index of 53. It means 53 articles of this journal have more than 53 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Hepatobiliary and Pancreatic Diseases International ISSN


The ISSN of Hepatobiliary and Pancreatic Diseases International is 14993872. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Hepatobiliary and Pancreatic Diseases International Rank and SCImago Journal Rank (SJR)


The overall rank of Hepatobiliary and Pancreatic Diseases International is 7217. According to SCImago Journal Rank (SJR), this journal is ranked 0.691. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Hepatobiliary and Pancreatic Diseases International by Year


Year SJR
2023/2024 Coming Soon
2022 0.691
2021 0.657
2020 0.846
2019 0.661
2018 0.560
2017 0.711
2016 0.693
2015 0.728
2014 0.599

Ranking of Hepatobiliary and Pancreatic Diseases International by Year


Year Ranking
2023/2024 Coming Soon
2022 7217
2021 7389
2020 5586
2019 7407
2018 8595
2017 6649
2016 6834
2015 6545
2014 7698

Hepatobiliary and Pancreatic Diseases International Publisher


Table Setting

Hepatobiliary and Pancreatic Diseases International is published by Elsevier (Singapore) Pte Ltd. It's publishing house is located in Singapore. Coverage history of this journal is as following: 2002-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Hepatobiliary and Pancreatic Diseases International is Hepatobiliary Pancreat. Dis. Int.. This abbreviation ('Hepatobiliary Pancreat. Dis. Int.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Hepatobiliary and Pancreatic Diseases International


If your research field is/are related to Gastroenterology (Q2); Hepatology (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Hepatobiliary and Pancreatic Diseases International?

Hepatobiliary and Pancreatic Diseases International latest impact IF is 1.89. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 2.22 (2020) and 1.34 (2018), respectively, in the last 9 years. Moreover, its average IS is 1.8 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Hepatobiliary and Pancreatic Diseases International?

The Hepatobiliary and Pancreatic Diseases International has an SJR (SCImago Journal Rank) of 0.691, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.846 in 2020 and the lowest being 0.560 in 2018. Furthermore, the average SJR of the Hepatobiliary and Pancreatic Diseases International over the previous 9-year period stands at 1.8.


What's the latest h-index of the Hepatobiliary and Pancreatic Diseases International?

The latest h-index of the Hepatobiliary and Pancreatic Diseases International is 53.


Who's the publisher of the Hepatobiliary and Pancreatic Diseases International?

The Hepatobiliary and Pancreatic Diseases International is published by the Elsevier (Singapore) Pte Ltd, with its country of publication being the Singapore.


What's the current ranking of the Hepatobiliary and Pancreatic Diseases International?

The Hepatobiliary and Pancreatic Diseases International is currently ranked 7217 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 5586 in 2020 and its lowest position of 8595 in 2018.


What's the abbreviation or short name for the Hepatobiliary and Pancreatic Diseases International?

The standard ISO4 abbreviation for the Hepatobiliary and Pancreatic Diseases International is Hepatobiliary Pancreat. Dis. Int..


Is the "Hepatobiliary and Pancreatic Diseases International" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Hepatobiliary and Pancreatic Diseases International is classified as a journal that the Elsevier (Singapore) Pte Ltd publishes.


What's the scope or major areas of the Hepatobiliary and Pancreatic Diseases International?

The Hepatobiliary and Pancreatic Diseases International encompasses the following areas:

  • Gastroenterology
  • Hepatology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Hepatobiliary and Pancreatic Diseases International?

The Hepatobiliary and Pancreatic Diseases International is assigned the following International Standard Serial Numbers (ISSN): 14993872.


What's the best quartile of the Hepatobiliary and Pancreatic Diseases International?

The best quartile for the Hepatobiliary and Pancreatic Diseases International is Q2 (2022).


What's the coverage history of the Hepatobiliary and Pancreatic Diseases International?

The Hepatobiliary and Pancreatic Diseases International coverage history can be summarized as follows: 2002-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Business Economics and Management journal 10343 Vilnius Gediminas Technical University 45 2.81
Indian Journal of Plastic Surgery journal 16018 Thieme Medical Publishers Inc. 37 0.65
Milan Journal of Mathematics journal 3120 Birkhauser Verlag Basel 28 1.79
Journal, Indian Academy of Clinical Medicine journal 24608 Indian Academy of Clinical Medicine 16 0.06
Journal of Sociolinguistics journal 5409 Wiley-Blackwell Publishing Ltd 61 1.96
International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS conference and proceedings 781 Association for Computing Machinery (ACM) 100 8.01
Journal of Sociology journal 6009 SAGE Publications Ltd 58 3.21
Rudarsko Geolosko Naftni Zbornik journal 14294 University of Zagreb, Faculty of Mining, Geology and Petroleum Engineering 17 1.48
Transactions on Embedded Computing Systems journal 6019 Association for Computing Machinery (ACM) 61 2.25
Metascience journal 13645 Springer Nature 3 0.13

Check complete list




Year wise Impact Score (IS) of Hepatobiliary and Pancreatic Diseases International

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.89
2021 1.99
2020 2.22
2019 1.86
2018 1.34
2017 1.51
2016 1.67
2015 1.87
2014 1.88



Top Journals/Conferences in Gastroenterology

Nature Reviews Gastroenterology and Hepatology
Nature Publishing Group | United Kingdom

Gut
BMJ Publishing Group | United Kingdom

Gastroenterology
W.B. Saunders Ltd | United Kingdom

Lancet Gastroenterology and Hepatology, The
Elsevier Ltd. | United Kingdom

Clinical Gastroenterology and Hepatology
W.B. Saunders Ltd | United Kingdom

JHEP Reports
Elsevier BV | Netherlands

Journal of Crohn's and Colitis
Oxford University Press | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

Gut Microbes
Landes Bioscience | United States

Cellular and Molecular Gastroenterology and Hepatology
Elsevier Inc. | United States

See All

Top Journals/Conferences in Hepatology

Nature Reviews Gastroenterology and Hepatology
Nature Publishing Group | United Kingdom

Gastroenterology
W.B. Saunders Ltd | United Kingdom

Journal of Hepatology
Elsevier | Netherlands

Lancet Gastroenterology and Hepatology, The
Elsevier Ltd. | United Kingdom

Hepatology
John Wiley and Sons Ltd | United States

Liver Cancer
S. Karger AG | Switzerland

Clinical Gastroenterology and Hepatology
W.B. Saunders Ltd | United Kingdom

JHEP Reports
Elsevier BV | Netherlands

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

Cellular and Molecular Gastroenterology and Hepatology
Elsevier Inc. | United States

See All